Related Experiment Video
Updated: Nov 19, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
The Brain-Gut Axis: Psychological Functioning and Inflammatory Bowel Diseases.
Spyros Peppas1, Claudia Pansieri2,3, Daniele Piovani2,3
1Department of Gastroenterology, Athens Naval Hospital, 11521 Athens, Greece.
The brain-gut axis impacts mental health in inflammatory bowel disease (IBD). Understanding these connections is crucial for better psychological support and improved quality of life for IBD patients.
Area of Science:
- Neurogastroenterology
- Psychiatry
- Immunology
Background:
- The brain-gut axis involves complex bidirectional communication between the brain and the gastrointestinal tract.
- Inflammatory bowel disease (IBD) is a chronic inflammatory condition with a multifactorial cause.
- Psychological issues like depression and anxiety are common in IBD patients but often under-diagnosed.
Purpose of the Study:
- To review the role of the brain-gut axis in the psychological functioning of IBD patients.
- To discuss current preclinical and clinical evidence on brain-gut interactions in IBD.
- To explore therapeutic strategies for managing psychological comorbidities in IBD.
Main Methods:
- Comprehensive literature review of preclinical and clinical studies.
- Analysis of research on the brain-gut axis and its implications for IBD.
- Synthesis of data on psychological disorders in IBD patients.
Main Results:
- The brain-gut axis significantly influences psychological well-being in individuals with IBD.
- Mechanisms linking IBD, depression, anxiety, and cognitive dysfunction require further elucidation.
- Current evidence highlights the need for integrated treatment approaches.
Conclusions:
- Psychological support tailored to individual needs is essential for improving the quality of life in IBD patients.
- Further research is needed to clarify the exact mechanisms of brain-gut interactions in IBD.
- Addressing psychological comorbidities is a critical component of comprehensive IBD management.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

